Initiatives

WELCOME TO INITITATIVES The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an essential…

Read More

GVN Members

WELCOME TO Members GVN REGIONAL HEADQUARTERS OVERVIEW The overall mission of a GVN Regional Headquarters office is to collaborate with the GVN global headquarters located in Baltimore, Maryland, USA. A GVN Regional HQ provides organizational support and leadership to strengthen basic and translational research in virology, as well as preparedness and response to viral pandemic…

Read More

Long COVID: The Impact of Post-Acute Sequelae of COVID-19 (PASC)

November 12, 2021 There is mounting evidence of the importance and seriousness of the long-term effects of COVID-19. Post-acute sequelae of SARS-CoV-2 (PASC, or “long COVID”) is characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms (1). Approximately 80% of individuals with a confirmed COVID-19 diagnosis continue to…

Read More

Footer

CONTACT US Copyright © 2024 · GVN · All Rights Reserved Site originally developed by Absolute Marketing Solutions

Read More

Header

Enter search terms here Search Intranet Login What We Do Action Committees Training and Education Meetings and Events Perspectives and PositionsWho We Are GVN Academic Centers of Excellence and Affiliates GVN Corporate and Institutional Partners GVN Center and Member Spotlights GVN Robert C. Gallo AwardGet InvolvedAbout Mission Board Team Press ContactIntranet Login — Coming Soon…

Read More

Home

Battling Pandemic Viruses Like Avian InfluenzaApril 29, 2024 Read more GVN Annual Meeting: Navigating Virology’s Frontiers in AfricaSave the date: September 16-18, 2024 GVN Meetings Dengue virus: Urgency in our warming worldJanuary 10, 2024 Read more Universal Access to New Vaccines in 2023: A Necessity for Public HealthNovember 7, 2023 Read more Responding to Long…

Read More

GVN Center and Member Spotlight – Osbourne Quaye

Members > Spotlights > Osbourne Quaye GVN Center and Member Spotlight Dr. Osbourne Quaye Head of the Virology Laboratory and Lead of Monitoring and Evaluation West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana Associate Professor and Head of Department Department of Biochemistry, Cell and Molecular Biology, University of Ghana What…

Read More

GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges

GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges Thursday, December 02, 2021 – Friday, December 03, 2021 Towards the deployment of a global and collaborative diagnostic arsenal to detect and fight against pandemics The current COVID-19 pandemic has again emphasized the importance of accurate, rapid, and massively deployed diagnostics to effectively contain viral transmission.…

Read More

New Antivirals: Could They Be Game Changers?

November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future, prevent infection after contamination. It is likely…

Read More

New Antivirals: Could They Be Game Changers?

New Antivirals: Could They Be Game Changers? November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future,…

Read More